keyword
https://read.qxmd.com/read/38354359/keratin-microspheres-as-promising-tool-for-targeting-follicular-growth
#21
JOURNAL ARTICLE
Meriem Bejaoui, Wey Yih Heah, Aprill Kee Oliva Mizushima, Mitsutoshi Nakajima, Hiroshi Yamagishi, Yohei Yamamoto, Hiroko Isoda
Skin is the body barrier that constrains the infiltration of particles and exogenous aggression, in which the hair follicle plays an important role. Recent studies have shown that small particles can penetrate the skin barrier and reach the hair follicle, making them a potential avenue for delivering hair growth-related substances. Interestingly, keratin-based microspheres are widely used as drug delivery carriers in various fields. In this current study, we pursue the effect of newly synthesized 3D spherical keratin particles on inducing hair growth in C57BL/6 male mice and in human hair follicle dermal papilla cells...
February 14, 2024: ACS Applied Bio Materials
https://read.qxmd.com/read/38346345/materiobiomodulated-ros-therapy-for-de-novo-hair-growth
#22
JOURNAL ARTICLE
Long Bai, Yifei Wang, Kun Wang, Xiaoqian Chen, Yuzheng Zhao, Changsheng Liu, Xue Qu
Hair loss is characterized by the inability of hair follicles (HFs) to enter the telogen-anagen transition (TAT) and lack of de novo HFs. Current pharmaceutical therapies and surgical modalities have been largely limited to regulating hair regrowth efficiently without side effects and lacking treatment compliance. Here, this work proposes a materiobiomodulation therapy (MBMT), wherein polydopamine (PDA) nanoparticles with redox activity can be modulated to have a stoichiometric ROS (H2 O2 ) donating ability...
February 12, 2024: Advanced Materials
https://read.qxmd.com/read/38342501/dupliumab-therapy-for-alopecia-areata-a-case-series-and-review-of-the-literature
#23
REVIEW
Jundong Huang, Jia Jian, Tingting Li, Min Li, Kaifu Luo, Sihan Deng, Yan Tang, Fangfen Liu, Zhixiang Zhao, Wei Shi, Ji Li
BACKGROUND: A growing body of research supports the important role of the TH2 axis in alopecia areata (AA). Dupilumab is a humanized monoclonal antibody against IL-4Rα that downregulates TH2 response. Although efficacy has been shown in clinical trials, real-world data on the use of dupilumab in AA patients is limited. OBJECTIVES: To report on a case series of 10 patients with AA who were treated with dupilumab and provide real-world evidence regarding its efficacy in treating severe AA...
December 2024: Journal of Dermatological Treatment
https://read.qxmd.com/read/38339167/quantitative-analysis-of-hair-luster-in-a-novel-ultraviolet-irradiated-mouse-model
#24
JOURNAL ARTICLE
Kyung Bae Chung, Young In Lee, Yoo Jin Kim, Hyeon Ah Do, Jangmi Suk, Inhee Jung, Do-Young Kim, Ju Hee Lee
Hair luster is a key attribute of healthy hair and a crucial aspect of cosmetic appeal, reflecting the overall health and vitality of hair. Despite its significance, the advancement of therapeutic strategies for hair luster enhancement have been limited due to the absence of an effective experimental model. This study aimed to establish a novel animal model to assess hair gloss, employing ultraviolet (UV) irradiation on C57BL/6 mice. Specifically, UVB irradiation was meticulously applied to the shaved skin of these mice, simulating conditions that typically lead to hair luster loss in humans...
February 4, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38321929/the-role-of-fractional-laser-assisted-drug-delivery-in-enhancing-the-efficacy-of-topical-bimatoprost-solution-in-the-treatment-of-alopecia-areata-an-intra-patient-comparative-randomized-clinical-trial
#25
JOURNAL ARTICLE
Simin Shamsi Meymandi, Alireza Safari, Manzumeh Shamsi Meymandi, Mahin Aflatoonian
BACKGROUND: Transepidermal drug delivery is a novel therapeutic technique to boost efficacy of topical drugs. AIM: In this clinical trial we evaluate the efficacy of the combination of fractional carbon dioxide (FCO2 ) laser and bimatoprost solution compared to bimatoprost alone in the treatment of alopecia areata. METHODS: This is a prospective intra-patient comparative randomized clinical trial on 20 patients with alopecia areata. In each participant two patches were chosen to randomly receive either topical 0...
February 7, 2024: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/38321607/concentrated-growth-factor-therapy-as-cosmetic-treatment-in-discoid-lupus-erythematosus
#26
JOURNAL ARTICLE
Xiao-Shuang Yang, Ting-Ting Wang, Yu-Xin Ding, Yu-Hong Chen, Zhong-Fa Lv
Discoid lupus erythematosus (DLE) is a disfigurement disease. The atrophic scar and hair loss of this disease are followed by cosmetic defects and profoundly impact psychological health. Concentrated growth factor (CGF) has been widely adopted in medical cosmetology. Here we report a 36-year-old female systemic lupus erythematosus patient with a 5-year history of alopecia in DLE, who was recommended for CGF therapy and experienced hair regrowth. We suggest that CGF may be an effective cosmetic treatment for DLE...
February 6, 2024: Journal of Dermatology
https://read.qxmd.com/read/38312246/establishing-the-financial-burden-of-alopecia-areata-and-its-predictors
#27
JOURNAL ARTICLE
Fabio Zucchelli, Matthew Harries, Andrew Messenger, Kerry Montgomery
BACKGROUND: Alopecia areata (AA) can have a significant impact on wellbeing. Consequently, individuals with AA often seek treatments or products to promote hair regrowth or camouflage their hair loss that incur a financial cost to the individual. OBJECTIVES: The current study aimed to examine the direct financial burden of AA to understand the wider impact of the condition and the factors which influence spending on products and services. METHODS: A total of 829 United Kingdom based participants completed an online survey...
February 2024: Skin Health Dis
https://read.qxmd.com/read/38298748/novel-application-of-1064-nm-picosecond-nd-yag-laser-for-male-androgenetic-alopecia-treatment
#28
JOURNAL ARTICLE
Suparuj Lueangarun, Therdpong Tempark
BACKGROUND: There are limitations and side effects of currently approved treatments for AGA, such as topical minoxidil, oral finasteride, and low-level light therapy. OBJECTIVE: This study aimed to investigate the potential of fractional picosecond laser (FPL) therapy for promoting hair regrowth. METHODS: This was a pilot study in which five male participants were treated with a 1064-nm FPL for mild-to-moderate AGA. The patients underwent three treatments at four-week intervals, followed by a four-week post-procedure assessment...
January 2024: Journal of Clinical and Aesthetic Dermatology
https://read.qxmd.com/read/38292710/prevalence-clinical-presentation-and-therapeutic-outcome-of-ectoparasitic-infestations-in-dogs-in-egypt
#29
JOURNAL ARTICLE
Hend Adel Zineldar, Nasser Zeidan Abouzeid, Mohamed Ibrahim Eisa, Emad Mohamed Bennour, Wafaa Mohamed El Neshwy
BACKGROUND: Skin diseases are usually chronic in nature but not life-threatening. They affect the well-being and pose a threat to the general health of the affected animals. AIM: This study aimed to investigate epidemiological, clinical, and therapeutic aspects of ectoparasitic infestations in dogs in a number of Egyptian governorates. METHODS: Ninety dogs (58 males and 32 females) aged from 1 month to 11 years from 6 Egyptian governorates were clinically examined during the years 2022 and 2023...
December 2023: Open Veterinary Journal
https://read.qxmd.com/read/38284194/a-clinical-investigation-of-early-onset-alopecia-areata-in-children-onset-earlier-than-4%C3%A2-years-of-age-might-have-a-better-short-term-prognosis
#30
JOURNAL ARTICLE
Ji-Hoon Lim, Soon-Hyo Kwon, Woo-Young Sim, Bark-Lynn Lew
Alopecia areata (AA) is a non-scarring autoimmune hair loss of the scalp or body. While an early onset is considered a primary factor for poor prognosis, children with early-onset AA show varied responses to treatment. This study aimed to describe the clinical characteristics and assess the prognostic factors of early-onset AA in children. We performed a retrospective study of AA patients aged <10 years who visited our dermatologic clinic between January 2013 and December 2020, with a follow-up period >12 months...
January 2024: Experimental Dermatology
https://read.qxmd.com/read/38282998/a-real-world-study-of-steroid-free-monotherapy-with-tofacitinib-in-severe-and-therapy-recalcitrant-alopecia-areata-alopecia-totalis-and-alopecia-universalis-cases-a-retrospective-analysis
#31
JOURNAL ARTICLE
Savitha Sharath, Kabir Sardana, Ananta Khurana
BACKGROUND: Alopecia areata (AA) presents with noncicatricial alopecia and has multifactorial etiology. Janus Kinase inhibitors (JAKibs) with potential efficacy and favorable side-effect profile are the first class of drugs to receive FDA approval in AA. OBJECTIVES: Our primary objective was to assess the complete response rates to tofacitinib monotherapy in severe and recalcitrant AA, alopecia totalis (AT), and alopecia universalis (AU) patients using the latest percentage change in Severity of alopecia tool (SALT) score...
2024: Indian Dermatology Online Journal
https://read.qxmd.com/read/38279559/comparative-efficacy-of-oral-janus-kinase-inhibitors-and-biologics-in-adult-alopecia-areata-a-systematic-review-and-bayesian-network-meta-analysis
#32
REVIEW
Husein Husein-ElAhmed, Sara Husein-ElAhmed
Alopecia areata (AA) is an autoimmune disorder that affects the hair follicles, resulting in patchy recurrent hair loss. A large body of evidence has demonstrated the favourable clinical response of the Janus kinase (JAK) inhibitors and biologics, but a lack of comprehensive comparison among these therapies exists in the current literature. This study aimed to compare their efficacy. A systematic review and meta-analysis were performed including randomized trials that report the outcomes of the Severity of Alopecia Tool (SALT)50 and/or the mean change in SALT...
January 26, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38277725/psychological-stress-induces-hair-regenerative-disorders-through-corticotropin-releasing-hormone-mediated-autophagy-inhibition
#33
JOURNAL ARTICLE
Wenzi Liang, Yinglin Zhao, Bozhi Cai, Yuxin Huang, Xiuwen Chen, Na Ni, Yingshan Wang, Zhaoping Lin, Changmin Lin, Keng Huang
Psychosocial stress is increasing, causing a growing number of people to suffer from hair loss. Stress-related corticotropin-releasing hormone (CRH) is associated with hair loss, but the mechanism by which hair follicles respond to stress and CRH remain poorly understood. The aim of the study is to elucidate the association between CRH and stress-related hair regenerative disorders, and reveal the potential pathological mechanisms. A chronic unpredictable stress mouse model and a chronic social defeat stress mouse model were used to examine the role of CRH and stress-related hair regrowth...
January 23, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38229856/oral-administration-of-lactilactobacillus-curvatus-lb-p9-promotes-hair-regeneration-in-mice
#34
JOURNAL ARTICLE
Mikyung Song, Jaeseok Shim, Kyoungsub Song
This study was designed to examine the effect of Lactilactobacillus curvatus LB-P9 on hair regeneration. The treatment of LB-P9 conditioned medium increased the proliferation of both hair follicle dermal papilla cells and hair germinal matrix cells (hGMCs). Moreover, the expression levels of hair growth factors such as vascular endothelial growth factor (VEGF) and fibroblast growth factor 7 were significantly elevated in hGMCs co-cultured with LB-P9. After time-synchronized depilation, mice were orally administered with either 4×107 colony forming unit (CFU) of LB-P9 (low dose) or 4×108 CFU of LB-P9 (high dose), once daily for 4 weeks...
January 2024: Food science of animal resources
https://read.qxmd.com/read/38193597/the-effect-of-oxygen-supply-using-perfluorocarbon-based-nanoemulsions-on-human-hair-growth
#35
JOURNAL ARTICLE
Phil June Park, Himangsu Mondal, Bong Soo Pi, Sung Tae Kim, Jun-Pil Jee
Hair dermal papilla cells (hDPCs) play a crucial role in hair growth and regeneration, and their function is influenced by nutrient and oxygen supply. A microenvironment with significantly low oxygen (O2 ) levels, known as anoxic conditions (<0.2%) due to oxygen deficiency, hinders hDPC promotion and retards hair regrowth. Here, a nanoemulsion (NE) based on perfluorooctyl bromide (PFOB), a member of the perfluorocarbon family, is presented to provide a sustainable O2 supply and maintain physical stability in vitro ...
January 9, 2024: Journal of Materials Chemistry. B, Materials for Biology and Medicine
https://read.qxmd.com/read/38188083/hair-growth-promoting-effects-of-rosehip-rosa-canina-l-seed-oil-in-c57bl-6-mice
#36
JOURNAL ARTICLE
Van-Long Truong, Woo-Sik Jeong
Rosehip ( Rosa canina L.) seeds, a by-product of the food processing industry, contain various bioactive compounds that have potential cosmetic and pharmacological applications. Rosehip seed oil (RHSO) has been shown to exert therapeutic effects in skin disorders, but its role in promoting hair growth remains unknown. In this study, we aimed to elucidate the hair growth-promoting activity of RHSO and the related mechanisms of action. The depleted dorsal skin of telogenic C57BL/6 mice was topically treated with RHSO for 21 days, and the extent of hair regrowth was assessed...
December 31, 2023: Preventive Nutrition and Food Science
https://read.qxmd.com/read/38173892/rare-oto-tricho-tussia-tinnitus-a-case-report
#37
Habib Azimi, Seyed Mohammad Tabibzadeh, Abbas Khalilpour, Mohsen Akbaribazm
KEY CLINICAL MESSAGE: Oto-tricho is associated with the symptoms of gag reflex and non-neuropathic tinnitus, which can be treated by removing the hair and its follicle. ABSTRACT: Oto-tricho refers to a disorder of hair growth in the tympanic membrane (TM). In its early stages, it can manifest as symptoms such as tinnitus, chronic pain, cough, and nausea. If left untreated, it can potentially lead to tympanosclerosis, TM micro-perforation, and hearing loss. In this report, we present a case study of a 33-year-old male with hair and follicle growth observed on the left TM...
January 2024: Clinical Case Reports
https://read.qxmd.com/read/38164355/status-of-research-on-the-development-and-regeneration-of-hair-follicles
#38
REVIEW
Dan Liu, Qi Xu, Xiangyuan Meng, Xiaomei Liu, Jinyu Liu
Hair loss, or alopecia, is a prevalent condition in modern society that imposes substantial mental and psychological burden on individuals. The types of hair loss, include androgenetic alopecia, alopecia areata, and telogen effluvium; of them, androgenetic alopecia is the most common condition. Traditional treatment modalities mainly involve medical options, such as minoxidil, finasteride and surgical interventions, such as hair transplantation. However, these treatments still have many limitations. Therefore, exploring the pathogenesis of hair loss, specifically focusing on the development and regeneration of hair follicles (HFs), and developing new strategies for promoting hair regrowth are essential...
2024: International Journal of Medical Sciences
https://read.qxmd.com/read/38155292/carbon-dioxide-fractional-laser-treatment-induces-lgr5-stem-cell-activation-and-hair-regrowth-through-the-canonical-wnt-%C3%AE-catenin-pathway
#39
JOURNAL ARTICLE
Ruishuang Sun, Yingxia Luo, Jiaxing Liu, Liujie Shi, Yunsong Zhang
BACKGROUND: Different types of alopecia have negative impacts on patients. Recently, some kinds of laser or light therapies have been reported to effectively alleviate hair loss. Carbon dioxide fractional laser (CO2 FL) treatment is one of the most effective laser treatments, but its beneficial effects and exact mechanism in hair regrowth have not been reported in detail. The purpose of this study was to investigate the effect and molecular mechanism further. METHODS: C57 and Lgr5-Cre: Rosa-mTmG mouse models of hair regrowth were established by CO2 FL treatment, and the parameters that induced the best effect were determined...
December 28, 2023: Aesthetic Plastic Surgery
https://read.qxmd.com/read/38112208/effectiveness-and-predictive-factors-of-response-to-tofacitinib-therapy-in-125-patients-with-alopecia-areata-a-single-centre-real-world-retrospective-study
#40
JOURNAL ARTICLE
Jundong Huang, Pei Qian, Yan Tang, Ji Li, Fangfen Liu, Wei Shi
Alopecia areata is an autoimmune disorder that greatly impacts patients' quality of life, and its management remains challenging. Tofacitinib is the first Janus kinase inhibitor to be approved for clinical use and is the most extensively studied. Several studies have demonstrated the clinical effectiveness of oral tofacitinib in treating patients with alopecia areata. However, despite being widely used in clinical practice, no prospective randomized controlled trials have been implemented and its indication criteria have not been thoroughly established...
December 19, 2023: Acta Dermato-venereologica
keyword
keyword
71764
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.